Chinese Herbal Medicines (CHM) is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences.

The purpose of CHM is to provide a forum for the studies on Chinese herbal medicines, traditional medicines, and natural products. The journal will accept the following contributions: research articles, review papers, short communications, letters to the editor, book reviews, conference announcements, and information, etc. The journal includes the studies on active ingredients and complex formulations of herb medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function by experimental and clinical trials. It is the interest of this journal to introduce the latest development in pharmaceutical sciences to readers.

The editorial committee is composed of 70 experts, among whom 12 are academicians of Chinese Academy of Engineering and Social Sciences, and 38 are from the oversea areas. The honorary editor-in-chief is Pei-gen Xiao, an academician of Chinese Academy of Engineering. The editor-in-chief is Chang-xiao Liu, an academician of Chinese Academy of Engineering, and the associate editors-in-chief are Prof. Shi-lin Chen, Prof. Thomas Efferth, Prof. De-an Guo, Prof. Pulok Kumar Mukherjee, Prof. Li-da Tang, and Prof. Guido F. Pauli.

Since foundation of CHM in 2009, it has been included in China Academic Journals Integrated Online Database, and Chemical Abstracts Service (CAS) in USA, Index Copernicus (IC) in Poland, and Ulrich's Periodicals Directory (UPD) in USA domestically and abroad. In 2011, it can also be cited in Global Health and CAB Abstract. In 2013, CHM can also be indexed in EMBASE in Holland. The CAS report revealed that of all the 49 articles published in CHM in 2012, 31 papers were included in CAS.